Cirrus Therapeutics
PrivateLast Round
Seed
Oct 2, 2025
Total Funding Raised
$11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cirrus Therapeutics is a biotechnology company developing gene and cell therapies for ocular immunology to treat conditions like age-related macular degeneration (AMD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cirrus Therapeutics Comparables
Compare Cirrus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Complement Therapeutics GmbH | 84% | |
| Luxa Biotechnology | 81% | |
| Perceive Bio | 81% | |
Cirrus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 2, 2025 |
Key People
Founding team and executive leadership
Cirrus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Seed |
| ClavystBio | Seed |
| Polaris Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2026
Grew 33% QoQ, from 9 to 12 employees.
- Apr 17, 2026
Grew 120% QoQ from 5 to 11 employees.
Cirrus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cirrus Therapeutics's valuation, stock price, and market status.